FdaApplication
NDA 021361
Identifiers
- fda_app_no: NDA021361
Properties
| Property | Value |
|---|---|
| applicant_name | SALIX PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2004-05-25 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| XIFAXAN | RIFAXIMIN | 550MG | TABLET;ORAL |
| XIFAXAN | RIFAXIMIN | 200MG | TABLET;ORAL |
2 products